Massimo Corradi Selected Research

Beclomethasone (Beclometasone)

1/2021	Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial.
1/2019	Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler.
1/2018	Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
1/2017	Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.
12/2016	High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.
10/2016	High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
9/2016	Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
1/2016	Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease.
9/2014	NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma.
3/2014	Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimo Corradi Research Topics

Disease

17	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 05/2003
14	Asthma (Bronchial Asthma) 01/2022 - 02/2003
11	Inflammation (Inflammations) 01/2022 - 08/2002
8	Lung Neoplasms (Lung Cancer) 10/2021 - 07/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2013 - 07/2005
4	Neoplasms (Cancer) 06/2021 - 07/2005
4	Pneumonia (Pneumonitis) 01/2020 - 08/2002
4	Infections 02/2009 - 12/2005
3	Dyspnea (Shortness of Breath) 01/2022 - 09/2016
3	Malignant Mesothelioma 06/2021 - 12/2013
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2012
3	Hypersensitivity (Allergy) 12/2019 - 05/2015
3	Lung Diseases (Lung Disease) 04/2019 - 01/2017
2	COVID-19 01/2022 - 10/2020
2	Bronchial Spasm 01/2019 - 10/2012
2	Asbestosis 01/2017 - 12/2013
2	Rhinitis 07/2009 - 01/2007
2	Cystic Fibrosis (Mucoviscidosis) 01/2008 - 12/2005
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Pregnancy Complications 01/2022
1	Mesothelioma 06/2021
1	Rare Diseases (Rare Disease) 04/2021
1	Leiomyoma (Uterine Fibroids) 04/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Tuberculosis (Tuberculoses) 06/2020
1	Fibrosis (Cirrhosis) 12/2019
1	Virus Diseases (Viral Diseases) 12/2019
1	Sarcoidosis (Schaumann Disease) 01/2017
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 12/2016
1	Immediate Hypersensitivity 12/2012
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2012
1	Respiratory Sounds (Crackle) 01/2012
1	Occupational Diseases (Occupational Disease) 01/2012
1	Diabetes Mellitus 06/2011
1	Pneumoconiosis 04/2010
1	Occupational Asthma 04/2010

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2002
13	Beclomethasone (Beclometasone)FDA Link 01/2021 - 10/2012
13	Formoterol Fumarate (Oxis)FDA Link 01/2021 - 10/2012
12	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2019 - 02/2004
4	AldehydesIBA 01/2022 - 02/2003
4	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 09/2016
4	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 09/2016
4	Muscarinic AntagonistsIBA 07/2019 - 01/2017
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 06/2006
3	MicroRNAs (MicroRNA)IBA 06/2021 - 12/2013
3	AsbestosIBA 04/2021 - 12/2013
3	AntigensIBA 06/2020 - 12/2012
3	Volatile Organic CompoundsIBA 10/2010 - 07/2005
3	Leukotriene B4IBA 10/2008 - 12/2005
2	Air Pollutants (Pollutants, Air)IBA 01/2022 - 10/2020
2	Biological ProductsIBA 04/2021 - 10/2008
2	LipidsIBA 01/2021 - 01/2008
2	SmokeIBA 12/2019 - 03/2007
2	Silicon Dioxide (Silica)FDA LinkGeneric 04/2019 - 12/2016
2	Methacholine Chloride (Methacholine)FDA Link 01/2019 - 10/2012
2	Pharmaceutical PreparationsIBA 01/2018 - 09/2016
2	Tiotropium Bromide (Spiriva)FDA Link 05/2017 - 01/2017
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 10/2016 - 03/2014
2	Albuterol (Salbutamol)FDA LinkGeneric 03/2013 - 10/2012
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2012 - 01/2008
2	MetalsIBA 06/2011 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 04/2010 - 01/2008
2	AntioxidantsIBA 01/2010 - 02/2003
2	Proteins (Proteins, Gene)FDA Link 01/2008 - 01/2007
2	cysteinyl-leukotrieneIBA 03/2007 - 02/2004
2	LeukotrienesIBA 03/2007 - 02/2004
2	SteroidsIBA 02/2004 - 02/2003
2	Malondialdehyde (Propanedial)IBA 05/2003 - 02/2003
1	ElementsIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	RadonIBA 10/2021
1	Progesterone FDA LinkGeneric 04/2021
1	Estrogens (Estrogen)FDA Link 04/2021
1	lysyl-5-fluorotryptophyl-lysine (Tri (D))IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	Tuberculin (PPD)IBA 06/2020
1	SolutionsIBA 06/2020
1	Particulate MatterIBA 01/2020
1	Stainless Steel (Steel, Stainless)IBA 01/2020
1	ClayIBA 04/2019
1	indacaterolIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2017
1	MineralsIBA 01/2017
1	ParaffinIBA 01/2017
1	Immunoglobulin E (IgE)IBA 05/2015
1	MesothelinIBA 12/2013
1	4-sulfophenylmethallyl ether (SPME)IBA 10/2010
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2010
1	Protein Isoforms (Isoforms)IBA 01/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2010

Therapy/Procedure

10	Therapeutics 01/2021 - 02/2003
5	Nebulizers and Vaporizers (Inhaler) 01/2021 - 01/2013
3	Dry Powder Inhalers 01/2021 - 09/2014
2	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 01/2019
2	Aftercare (After-Treatment) 05/2014 - 01/2012
1	Critical Care (Surgical Intensive Care) 01/2012